Don't Shy Away From Selective Beta-Blockers in Most COPD or Asthma Patients
May 2019
We're still getting questions about whether beta-blockers are safe for patients with COPD or asthma.
Many of us were taught to avoid beta-blockers in these patients...because of concerns about bronchoconstriction.
But cardioSELECTIVE options (metoprolol, bisoprolol, etc) don't cause more exacerbations or reduce airway function in COPD or asthma. And patients still respond to beta-agonists (albuterol, salmeterol, etc).
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote